10-K
Annual Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
35 line items · 2 periods
XBRL
| Item | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 5,439,000 | 27,053,000 |
Cash and Cash Equivalents | 7,631,000 | 7,137,000 |
Fair Value, Inputs, Level 1 | 7,631,000 | 7,137,000 |
Accounts Receivable | 1,184,000 | 1,676,000 |
Other Non-Operating Current Assets | 302,000 | 455,000 |
Total current assets | 14,556,000 | 36,321,000 |
Property, Plant and Equipment | 127,000 | 195,000 |
Operating Lease Right-of-Use Asset | 697,000 | 829,000 |
Intangible Assets | 2,313,000 | 1,941,000 |
Patents | 2,197,000 | 1,794,000 |
Trademarks | 116,000 | 147,000 |
Other Non-Operating Non-Current Assets | 1,688,000 | 1,202,000 |
Total assets | 19,381,000 | 40,488,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 6,443,000 | 377,000 |
Other Current Liabilities | 1,986,000 | 806,000 |
Operating Lease Liability, Current | 223,000 | 178,000 |
Total current liabilities | 8,652,000 | 1,361,000 |
Long-term liability: | ||
Operating Lease Liability, Non-Current | 495,000 | 659,000 |
Total liabilities | 9,147,000 | 2,020,000 |
Stockholders’ equity: | ||
Series B Convertible Preferred Stock | 689,000 | 696,000 |
Total Stockholders' Equity | 49,000 | 48,000 |
Total Stockholders' Equity | 419,004,000 | 418,270,000 |
Total Stockholders' Equity | (409,508,000) | (380,546,000) |
Total stockholders’ equity | 10,234,000 | 38,468,000 |
Series B Preferred Stock - Common Stock | 689,000 | 696,000 |
Common Stock | 49,000 | 48,000 |
Additional Paid-in Capital | 419,004,000 | 418,270,000 |
Retained Earnings | (409,508,000) | (380,546,000) |
Total liabilities and stockholders’ equity | 19,381,000 | 40,488,000 |